103
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Magnesium Sulfate Does Not Protect Spinal Cord Against Ischemic Injury

, MD, , MD, , MD, , MD, , MD & , MD
Pages 250-256 | Received 11 Mar 2011, Accepted 17 May 2011, Published online: 02 Nov 2011
 

ABSTRACT

Objective: We tested various doses of MgSO4 to investigate the effect of Mg on a spinal cord ischemia. Methods: Rats were treated with either MgSO4 (30, 100, or 300 mg/kg; group Mglow, group Mgmedium, group Mghigh, respectively, n = 10 for each) or saline (control group; n = 10) before ischemia. Spinal cord ischemia was induced using a balloon-tipped catheter placed on proximal descending aorta. During surgery, hemodynamic variables were recorded before ischemia, during aortic occlusion and after reperfusion. Neurologic function was assessed using the motor deficit index (MDI; 0 = normal, 6 = complete paralysis) until seven days after reperfusion, and histologic examination of spinal cord was performed. Results: After reperfusion, the mean arterial pressure in the group Mghigh was significantly lower than other groups. Compared to the control group, the groups Mglow and Mgmedium did not show any difference in MDI and the group Mghigh showed significantly higher MDI. The number of normal motor neurons was similar among other groups except the group Mghigh had a significantly fewer normal motor neurons. Conclusions: Intravenous MgSO4 with low or medium dose (30, or 100 mg/kg) did not improve neurological injury following spinal cord ischemia. Furthermore, higher dose of MgSO4 (300 mg/kg) resulted in hemodynamic instability and aggravated neurologic outcome.

ACKNOWLEDGMENTS

This study was supported by grant number 11-2009-028 from Seoul National University Bundang Hospital research fund.

Declaration of Interest: The authors report no conflict of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.